Title
A photograph of a newspaper article titled "Mallinckrodt Launches Generic Version of CONCERT® in U.S. Company to hold six-month exclusivity on 27 36 and 54 milligram dosage strengths of ADHD treatment. St. Louis December 31 2012. The article is dated December 31st 2012 and is published by the Pharmaceuticals Business of Covidien. The article mentions that the company has received approval from the U. S. Food and Drug Administration (FDA) to manufacture and market a generic version of CONCERTRA® (Methylphenidate HCI) Extended-Release (ER) Tablets. The company will launch Methylphenidine HCI tablets in the 27 mg dosage strength immediately.
Category
Source 1 of 2
-
Date
2013
Collection
-
Date
2013
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.